Publication | Open Access
TNF-α-Induced YAP/TAZ Activity Mediates Leukocyte-Endothelial Adhesion by Regulating VCAM1 Expression in Endothelial Cells
65
Citations
30
References
2018
Year
Endothelial CellsCell AdhesionImmune RegulationImmunologyCellular PhysiologyInflammationTranscriptional RegulationAngiogenesisSignaling PathwayCell SignalingMolecular SignalingEndothelial Cell PathobiologyVcam1 ExpressionVascular PharmacologyVascular BiologyVessel HomeostasisNeovascularizationVascular Barrier StabilizationCell BiologyCytokineHippo PathwaySignal TransductionEndothelial DysfunctionCell-matrix InteractionMedicineCell Development
YAP/TAZ, a transcriptional co-activator of Hippo pathway, has emerged as a central player in vessel homeostasis such as sprouting angiogenesis and vascular barrier stabilization, during development. However, the role of YAP/TAZ in pathological angiogenesis remains unclear. Here, we demonstrated that YAP/TAZ is a critical mediator in leukocyte-endothelial adhesion induced by the vascular inflammatory cytokine TNF-α. YAP/TAZ was dephosphorylated, translocated from the cytosol to the nucleus, and activated by TNF-α in endothelial cells. A specific inhibitor of Rho GTPases suppressed the TNF-α-induced dephosphorylation of YAP. Knockdown of YAP/TAZ using siRNA significantly reduced the expression of the leukocyte adhesion molecule VCAM1 induced by TNF-α. The adhesion of monocytes to endothelial cells was also markedly reduced by YAP/TAZ silencing. However, knockdown of YAP/TAZ did not affect TNF-α-induced NF-κB signaling. Overall, these results suggest that YAP/TAZ plays critical roles in regulating TNF-α-induced endothelial cell adhesive properties without affecting the NF-κB pathway, and implicate YAP/TAZ as a potential therapeutic target for treating inflammatory vascular diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1